Addex Therapeutics Ltd ADR (ADXN) Stock Price, Quote & News

Company Profile

Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for neurological disorders in Switzerland. The company focuses on the discovery of G-protein coupled receptors and enzymes. Its lead programs include Dipraglurant, which is in phase 1 clinical trial for the treatment of post-stroke/TBI recovery, as well as to treat Parkinson's disease levodopa-induced dyskinesia. The company also develops ADX71149, a novel orally active metabotropic glutamate re...

Industry: Biotechnology

Sector: Healthcare

Phone: 41 22 884 1555

Fax: 41 22 884 1556

Website: www.addextherapeutics.com

Address:

Chemin des Mines, 9, Geneva, Switzerland

OfficialStocktwitsUser May. 6 at 10:55 AM

$ADXN RSI: 48.50, MACD: 0.0675 Vol: 0.25, MA20: 6.81, MA50: 6.74 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

StocktwitsEarnings Apr. 30 at 12:00 PM

$ADXN Q2 '25 Earnings Results & Recap Addex Therapeutics reported a net loss of CHF6.7M for 2025, compared to a net profit of CHF7.1M in 2024, with basic and diluted loss per share at CHF 0.06. Cash position was CHF1.6M.

0 · Reply

flybyme Apr. 21 at 6:39 PM

$ADXN https://www.addextherapeutics.com/en/investors/press-releases/addex-gabab-pam-candidate-demonstrates-robust-anti-tussive-activity-non-human-primate-chronic-cough-model/

0 · Reply

MetricWhale Apr. 15 at 4:20 PM

$ADXN up 24% pulling towards 8+ soon

0 · Reply

sb1971 Apr. 14 at 1:53 PM

$ADXN One of this days, this will hit!!

1 · Reply

MetricWhale Apr. 14 at 1:48 PM

$ADXN creeping towards the mark

0 · Reply

flybyme Apr. 10 at 12:52 PM

$ADXN when will the pumpers be back for the few days, normally every 6 months.

0 · Reply

MetricWhale Apr. 3 at 3:28 PM

$ADXN watch it down here, can spring to 8+ on right volume day

0 · Reply

ElevenXProfits Feb. 26 at 8:40 PM

$ADXN Added a lotto before the volume spikes, Very tiny float just needs news and she goes double digits

0 · Reply

OfficialStocktwitsUser Feb. 19 at 2:27 PM

$ADXN RSI: 39.64, MACD: -0.1477 Vol: 0.26, MA20: 7.78, MA50: 7.90 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

Q4 2025 Addex Therapeutics Ltd Earnings Call Transcript

Apr 30, 2026, 10:00 AM EDT - 12 days ago

Addex Therapeutics Earnings Call Transcript: H2 2025

Thu, 30 Apr 2026 01:00:00 -0400 - 13 days ago

Addex Reports Full Year 2025 Financial Results and Provides Corporate Update

2026-04-29T11:28:56.000Z - 14 days ago

Addex Therapeutics (ADXN) Reveals Promising Preclinical Results for Chronic Cough Treatment

2026-04-29T09:35:53.000Z - 14 days ago

Addex Therapeutics announces GABAB PAM candidate data

Wed, 29 Apr 2026 01:00:00 -0400 - 14 days ago

Addex GABAB PAM Candidate Demonstrates Solid Anti-Tussive Activity in Bleomycin IPF-Related Chronic Cough Model

2026-04-23T11:25:33.000Z - 20 days ago

Addex Therapeutics (ADXN) Sees Progress with Neurosterix's Clinical Study

2026-04-23T09:46:20.000Z - 20 days ago

Addex Therapeutics says spin-out company to complete NTX-253 study in Q2

2026-04-21T09:09:28.000Z - 22 days ago

Addex Reports Strong Anti-Tussive For GABAB PAM Candidate

Tue, 21 Apr 2026 01:00:00 -0400 - 22 days ago

Addex GABAB PAM Candidate Demonstrates Robust Anti-Tussive Activity in Non-Human Primate Chronic Cough Model

2026-03-18T16:05:59.000Z - 7 weeks ago

Addex Therapeutics Ltd – ADR trading resumes

2026-03-18T16:02:42.000Z - 7 weeks ago

Addex Therapeutics Ltd – ADR trading halted, volatility trading pause

2026-02-03T11:26:35.000Z - 3 months ago

Addex Therapeutics (ADXN) Publishes Promising Research on Anxiety Treatment

2026-02-03T10:40:43.000Z - 3 months ago

Addex publishes negative allosteric modulators data in Molecular Psychiatry

2026-01-13T17:31:18.000Z - 4 months ago

Addex Therapeutics Ltd – ADR trading resumes

2026-01-13T17:20:16.000Z - 4 months ago

Addex Therapeutics Ltd – ADR trading halted, volatility trading pause

2026-01-07T10:26:34.000Z - 4 months ago

Addex Therapeutics (ADXN) Advances NTX-253 into Clinical Trials for Schizophrenia

2026-01-07T10:10:23.000Z - 4 months ago

Addex Therapeutics spin-out Neurosterix starts NTX-253 study

Wed, 07 Jan 2026 01:00:00 -0500 - 4 months ago

Addex Spin-Out Neurosterix has started a Phase 1 Clinical Study with M4 PAM - NTX-253 for Schizophrenia

Thu, 11 Dec 2025 01:00:00 -0500 - 5 months ago

Addex Amends its at the Market Offering Agreement With H.C. Wainwright & Co.

2025-12-04T23:06:42.000Z - 5 months ago

Addex Therapeutics Ltd (ADXN) Q3 2025 Earnings Call Highlights: Strategic Advances Amidst ...

2025-12-04T22:03:09.000Z - 5 months ago

Q3 2025 Addex Therapeutics Ltd Earnings Call Transcript

Dec 4, 2025, 10:00 AM EST - 5 months ago

Addex Therapeutics Earnings Call Transcript: Q3 2025

2025-12-04T11:11:11.000Z - 5 months ago

Earnings Scheduled For December 4, 2025

Thu, 04 Dec 2025 01:00:00 -0500 - 5 months ago

Addex Therapeutics Reports 2025 Third Quarter Financial Results and Provides Corporate Update

Mon, 01 Dec 2025 01:00:00 -0500 - 5 months ago

Addex Therapeutics to Report 2025 Third Quarter Financial Results And Host Conference Call on December 4, 2025

2025-11-19T21:05:43.000Z - 6 months ago

Addex Therapeutics files to sell $150M in ordinary shares

2025-10-01T21:01:16.000Z - 7 months ago

Addex Therapeutics Ltd (ADXN) Q2 2025 Earnings Call Highlights: Strategic Advances Amid ...

2025-10-01T20:01:07.000Z - 7 months ago

Q2 2025 Addex Therapeutics Ltd Earnings Call Transcript

Oct 1, 2025, 10:00 AM EDT - 7 months ago

Addex Therapeutics Earnings Call Transcript: H1 2025

2025-09-30T08:32:10.000Z - 8 months ago

Earnings Scheduled For September 30, 2025

2025-09-30T07:34:43.000Z - 8 months ago

Addex Therapeutics Slips To Q2 Net Loss With Lower Income

Tue, 30 Sep 2025 01:00:00 -0400 - 8 months ago

Addex Therapeutics Reports 2025 Half Year and Second Quarter Financial Results and Provides Corporate Update

Fri, 26 Sep 2025 01:00:00 -0400 - 8 months ago

Addex Therapeutics to Report 2025 Half-year and Second Quarter Financial Results on September 30, 2025 and Host Conference Call on October 1, 2025

Tue, 23 Sep 2025 01:00:00 -0400 - 8 months ago

Addex Appoints Bank of New York Mellon as Depositary Bank

2025-09-12T09:19:19.000Z - 8 months ago

Why Adobe Shares Are Trading Higher By Over 4%; Here Are 20 Stocks Moving Premarket

2025-09-01T08:32:07.000Z - 9 months ago

Earnings Scheduled For September 1, 2025

Mon, 30 Jun 2025 01:00:00 -0400 - 11 months ago

Stalicla Secures CHF 2 Million Financing Led by Addex Therapeutics to Advance Precision Medicine Neurodevelopmental Disorder Programs

Mon, 30 Jun 2025 01:00:00 -0400 - 11 months ago

Addex Leads CHF 2 Million Investment in Stalicla to Advance Precision Medicine in Neuropsychiatric Disorders

Wed, 25 Jun 2025 01:00:00 -0400 - 11 months ago

Addex Shareholders Approve All Resolutions at Annual General Meeting

2025-06-20T13:46:04.000Z - 11 months ago

Addex Therapeutics Ltd – ADR trading resumes

2025-06-20T13:35:16.000Z - 11 months ago

Addex Therapeutics Ltd – ADR trading halted, volatility trading pause

Jun 19, 2025, 10:00 AM EDT - 11 months ago

Addex Therapeutics Earnings Call Transcript: Q1 2025

2025-06-19T08:32:07.000Z - 11 months ago

Earnings Scheduled For June 19, 2025

Thu, 19 Jun 2025 01:00:00 -0400 - 11 months ago

Addex Therapeutics Reports Q1 2025 Financial Results and Provides Corporate Update

Wed, 18 Jun 2025 01:00:00 -0400 - 11 months ago

Addex Therapeutics to Release Q1 2025 Financial Results and Host Conference Call on June 19, 2025

2025-06-06T09:10:36.000Z - 1 year ago

Addex reports anti-tussive activity of GABAB positive allosteric modulator

Fri, 06 Jun 2025 01:00:00 -0400 - 1 year ago

Addex GABAB PAM Candidate Demonstrates Robust Anti-Tussive Activity in Multiple Chronic Cough Preclinical Models

Tue, 03 Jun 2025 01:00:00 -0400 - 1 year ago

Addex Convenes Annual General Meeting 2025

Mon, 12 May 2025 01:00:00 -0400 - 1 year ago

Addex Partner Indivior Advances GABAB Positive Allosteric Modulator Program Successfully Through IND Enabling Studies

2025-04-30T09:40:58.000Z - 1 year ago

Addex Therapeutics enters collaboration with Sinntaxis AB

Apr 30, 2025, 1:00 AM EDT - 1 year ago

Addex Enters Option Agreement with Sinntaxis for an Exclusive License to Intellectual Property Covering the Use of mGlu5 Inhibitors in Brain Injury Recovery

Apr 25, 2025, 1:00 AM EDT - 1 year ago

Addex Reports Full Year 2024 Financial Results and Provides Corporate Update

2025-04-17T09:25:56.000Z - 1 year ago

Addex Therapeutics regains rights to ADX71149

JNJ

Apr 17, 2025, 1:00 AM EDT - 1 year ago

Addex Regains Rights to Phase 2 mGlu2 PAM Asset ADX71149

Jan 8, 2025, 1:00 AM EST - 1 year ago

Addex to Present at the 2025 Swiss Equities Baader Conference

Nov 22, 2024, 1:00 AM EST - 1 year ago

Addex Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Nov 11, 2024, 1:00 AM EST - 1 year ago

Addex Provisional 2024 Third Quarter Results Showed Net Loss Compared to Second Quarter 2024

2024-09-30T09:30:24.000Z - 1 year ago

Addex Therapeutics reports Q2 EPS CHF 0.08 vs. (CHF 0.04) last year

Sep 30, 2024, 1:00 AM EDT - 1 year ago

Addex Therapeutics Reports 2024 Half Year and Second Quarter Financial Results and Provides Corporate Update

Sep 19, 2024, 1:00 AM EDT - 1 year ago

Addex Provisional 2024 Half-Year and Second Quarter Result increased from a Net loss to a Net Profit

Sep 4, 2024, 1:00 AM EDT - 1 year ago

Addex to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

2024-08-28T13:21:44.000Z - 1 year ago

Clinical Collaboration Ignites Addex Therapeutics (ADXN) Stock Rally

Aug 27, 2024, 10:47 AM EDT - 1 year ago

Why Addex Therapeutics stock skyrocketed 70% on Tuesday

Aug 27, 2024, 1:00 AM EDT - 1 year ago

Addex and Indivior Select Clinical Candidates from GABAB Positive Allosteric Modulator Research Collaboration

2024-07-31T10:23:20.000Z - 1 year ago

Addex Therapeutics upgraded to Buy from Neutral at H.C. Wainwright

2024-07-22T09:34:06.000Z - 1 year ago

Addex Therapeutics partner discontinues development of ADX71149

Jul 22, 2024, 1:00 AM EDT - 1 year ago

Addex's Partner Discontinues ADX71149 development in Epilepsy

2024-07-15T09:19:59.000Z - 1 year ago

Addex Therapeutics presents results from GABAB PAM cough program

Jul 15, 2024, 1:00 AM EDT - 1 year ago

Addex Presents Positive Results from GABAB PAM Cough Program at the Thirteenth London International Cough Symposium (13th LICS)

Jul 12, 2024, 1:00 AM EDT - 1 year ago

Addex To Present at the Thirteenth London International Cough Symposium (13th LICS)

Jun 6, 2024, 1:00 AM EDT - 2 years ago

Addex Therapeutics Reports Q1 2024 Financial Results and Provides Corporate Update

Jun 5, 2024, 1:00 AM EDT - 2 years ago

Addex Convenes Annual General Meeting 2024

May 31, 2024, 1:00 AM EDT - 2 years ago

Addex Therapeutics to Release Q1 2024 Financial Results and Host Conference Call on June 6, 2024

May 8, 2024, 1:00 AM EDT - 2 years ago

Addex to Present at Bio€quity Europe 2024

Apr 29, 2024, 1:00 AM EDT - 2 years ago

Addex Provides Update on ADX71149 Phase 2 Epilepsy Study

Apr 19, 2024, 1:00 AM EDT - 2 years ago

Addex to Present at the Swiss Biotech Day 2024

Apr 18, 2024, 1:00 AM EDT - 2 years ago

Addex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate Update

Apr 11, 2024, 1:00 AM EDT - 2 years ago

Addex Therapeutics to Release Full-Year 2023 Financial Results and Host Conference Call on April 18, 2024

Apr 3, 2024, 1:00 AM EDT - 2 years ago

Addex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Modulator Therapeutics for Neurological Disorders

Mar 14, 2024, 2:00 AM EDT - 2 years ago

Addex to Present at the Bio-Europe Spring 2024 Conference

Jan 31, 2024, 1:00 AM EST - 2 years ago

Addex Enters into At-The-Market ADS Offering Agreement with H.C. Wainwright & Co. LLC.

Jan 9, 2024, 1:00 AM EST - 2 years ago

Addex to Present at the Swiss Equities Baader Conference

Jan 5, 2024, 1:30 AM EST - 2 years ago

Addex to Present at Biotech Showcase™ 2024

Dec 20, 2023, 1:00 AM EST - 2 years ago

Addex Shareholders Approve All Resolutions at Extraordinary General Meeting

Dec 14, 2023, 1:00 AM EST - 2 years ago

Addex Creates Treasury Shares

Nov 29, 2023, 1:00 AM EST - 2 years ago

Addex Reports Q3 2023 Financial Results and Provides Corporate Update

Nov 28, 2023, 1:00 AM EST - 2 years ago

Addex Convenes Extraordinary General Meeting

Nov 23, 2023, 1:00 AM EST - 2 years ago

Addex Therapeutics to Release Third Quarter 2023 Financial Results and Host Conference Call on November 29, 2023

OfficialStocktwitsUser May. 6 at 10:55 AM

0 · Reply

StocktwitsEarnings Apr. 30 at 12:00 PM

0 · Reply

flybyme Apr. 21 at 6:39 PM

$ADXN https://www.addextherapeutics.com/en/investors/press-releases/addex-gabab-pam-candidate-demonstrates-robust-anti-tussive-activity-non-human-primate-chronic-cough-model/

0 · Reply

MetricWhale Apr. 15 at 4:20 PM

$ADXN up 24% pulling towards 8+ soon

0 · Reply

sb1971 Apr. 14 at 1:53 PM

$ADXN One of this days, this will hit!!

1 · Reply

MetricWhale Apr. 14 at 1:48 PM

$ADXN creeping towards the mark

0 · Reply

flybyme Apr. 10 at 12:52 PM

$ADXN when will the pumpers be back for the few days, normally every 6 months.

0 · Reply

MetricWhale Apr. 3 at 3:28 PM

$ADXN watch it down here, can spring to 8+ on right volume day

0 · Reply

ElevenXProfits Feb. 26 at 8:40 PM

$ADXN Added a lotto before the volume spikes, Very tiny float just needs news and she goes double digits

0 · Reply

OfficialStocktwitsUser Feb. 19 at 2:27 PM

0 · Reply

OfficialStocktwitsUser Feb. 19 at 3:27 AM

$ADXN RSI: 39.64, MACD: -0.1477 Vol: 0.26, MA20: 7.78, MA50: 7.90 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

flybyme Feb. 3 at 3:51 PM

$ADXN And what happened nothing. Oh well same old story for years.

0 · Reply

flybyme Feb. 3 at 3:51 PM

$ADXN https://www.addextherapeutics.com/en/investors/press-releases/addex-announces-publication-preclinical-data-supporting-potential-mglu7-negative-allosteric-modulators-transform-anxiety-and-fea/

0 · Reply

BenKaitz Jan. 13 at 5:34 PM

$ADXN halted while going up

0 · Reply

astro_zombie Jan. 13 at 5:20 PM

$ADXN wtf is going on here?

0 · Reply

Mrious Jan. 13 at 5:18 PM

$ADXN HALTED low volume. Let’s see what this does. $AHMA

0 · Reply

MarketClarityX Dec. 27 at 6:27 AM

$ADXN Investor attention is skewing toward repeatable operating performance instead of aspirational projections. Resource allocation choices will signal strategic maturity. Transparency improvements could narrow valuation spreads. As performance stabilizes, the path forward can strengthen.

0 · Reply

ALRAE Dec. 22 at 1:32 AM

0 · Reply

Market Cap	8.45M
Revenue (ttm)	460,000.00
Net Income (ttm)	8.01M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	1,741.30%
Debt to Equity Ratio	0.00

Volume	300
Avg Vol	4,436
Day's Range	N/A - N/A
Shares Out	1.23M
Stochastic %K	53%
Beta	1.51
Analysts	Strong Buy
Price Target	$30.00